Severe exacerbations in moderate-to-severe asthmatics are associated with increased pro-inflammatory and type 1 mediators in sputum and serum

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1471-2466
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
Severe exacerbations in moderate-to-severe asthmatics are associated with increased pro-inflammatory and type 1 mediators in sputum and serum ; volume:19 ; number:1 ; day:8 ; month:8 ; year:2019 ; pages:1-10 ; date:12.2019
BMC pulmonary medicine ; 19, Heft 1 (8.8.2019), 1-10, 12.2019

Creator
Ghebre, Michael A.
Pang, Pee Hwee
Desai, Dhananjay
Hargadon, Beverley
Newby, Chris
Woods, Joanne
Rapley, Laura
Cohen, Suzanne E.
Herath, Athula
Gaillard, Erol A.
May, Richard D.
Brightling, Chris E.
Contributor
SpringerLink (Online service)

DOI
10.1186/s12890-019-0906-7
URN
urn:nbn:de:101:1-2019122907100174150303
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
14.08.2025, 10:57 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Ghebre, Michael A.
  • Pang, Pee Hwee
  • Desai, Dhananjay
  • Hargadon, Beverley
  • Newby, Chris
  • Woods, Joanne
  • Rapley, Laura
  • Cohen, Suzanne E.
  • Herath, Athula
  • Gaillard, Erol A.
  • May, Richard D.
  • Brightling, Chris E.
  • SpringerLink (Online service)

Other Objects (12)

Prognostic risk factors for moderate-to-severe exacerbations in patients with chronic obstructive pulmonary disease: a systematic literature review

Prognostic risk factors for moderate-to-severe exacerbations in patients with chronic obstructive pulmonary disease: a systematic literature review

Cost-Effectiveness of Acthar Gel Versus Standard of Care for the Treatment of Exacerbations in Moderate-to-Severe Systemic Lupus Erythematosus

Cost-Effectiveness of Acthar Gel Versus Standard of Care for the Treatment of Exacerbations in Moderate-to-Severe Systemic Lupus Erythematosus

Increased Small Intestinal Permeability during Severe Acute Exacerbations of COPD

Increased Small Intestinal Permeability during Severe Acute Exacerbations of COPD

Lebrikizumab for the Treatment of Moderate-to-Severe Atopic Dermatitis

Lebrikizumab for the Treatment of Moderate-to-Severe Atopic Dermatitis

Omalizumab in patients with severe asthma and persistent sputum eosinophilia

Omalizumab in patients with severe asthma and persistent sputum eosinophilia

Management of severe acute exacerbations of COPD: an updated narrative review

Management of severe acute exacerbations of COPD: an updated narrative review

Treatments for Moderate-to-Severe Alopecia Areata: A Systematic Narrative Review

Treatments for Moderate-to-Severe Alopecia Areata: A Systematic Narrative Review

Celiac Disease in Children with Moderate-to-Severe Iron-deficiency Anemia

Celiac Disease in Children with Moderate-to-Severe Iron-deficiency Anemia

Sputum ACE2, TMPRSS2 and FURIN gene expression in severe neutrophilic asthma

Sputum ACE2, TMPRSS2 and FURIN gene expression in severe neutrophilic asthma

Teprotumumab: The Dawn of Therapies in Moderate-to-Severe Thyroid-Associated Ophthalmopathy

Teprotumumab: The Dawn of Therapies in Moderate-to-Severe Thyroid-Associated Ophthalmopathy

MP-AzeFlu in Moderate-to-Severe Allergic Rhinitis: A Literature Review

MP-AzeFlu in Moderate-to-Severe Allergic Rhinitis: A Literature Review

Health Economic Assessment of Optimal Biological Treatment for Moderate-to-Severe Psoriasis

Health Economic Assessment of Optimal Biological Treatment for Moderate-to-Severe Psoriasis

Related objects